Sugi Predict

Sugi Predict / Compounds / SCHEMBL2322145

SCHEMBL2322145

SCHEMBL2322145

CSc1ccc(C(=O)c2cnc3[nH]ccc3c2Cl)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AXL P30530 1/20 0.51
▸ PRKCI P41743 1/20 0.51
▸ PLK1 P53350 1/20 0.41
▸ MGLL Q99685 3/20 0.38
▸ TTBK1 Q5TCY1 3/20 0.38
▸ TTBK2 Q6IQ55 3/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ PDE4A P27815 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ PMP22 Q01453 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ PDE4C Q08493 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12876007 0.84 AXL (0.53) AXLPRKCIMGLLTTBK1TTBK2
SCHEMBL1933959 0.84 AXL (0.50) AXLPRKCICYP1A2CYP2C9CYP3A4
SCHEMBL29378769 0.78 AXL (0.55) AXLPRKCIJAK2JAK1JAK3
SCHEMBL12876546 0.78 AXL (0.55) AXLPRKCIJAK2JAK1JAK3
SCHEMBL16261067 0.78 AXL (0.49) AXLPRKCIMGLLJAK2JAK1
SCHEMBL1154022 0.76 AXL (0.56) AXLPRKCIMGLLJAK2JAK1
SCHEMBL29588316 0.76 AXL (0.56) AXLPRKCIMGLLJAK2JAK1
SCHEMBL28735132 0.76 AXL (0.56) AXLPRKCIMGLLJAK2JAK1
SCHEMBL29588238 0.76 AXL (0.56) AXLPRKCIMGLLJAK2JAK1
SCHEMBL30985188 0.75 AXL (0.55) AXLPRKCIMGLLTTBK1TTBK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140349970-A1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC. (US) 2014-11-27 — — US disclosed
US-8785639-B2 Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof ABBVIE INC. (US) 2014-07-22 — — US disclosed
US-8785639-B2 Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof ABBVIE INC. (US) 2014-07-22 — — US disclosed
US-8785639-B2 Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof ABBVIE INC. (US) 2014-07-22 — — US disclosed
US-20110190489-A1 Novel Tricyclic Compounds ABBOTT LABORATORIES (US) 2011-08-04 — — US disclosed
US-20110190489-A1 Novel Tricyclic Compounds ABBOTT LABORATORIES (US) 2011-08-04 — — US disclosed
US-20110190489-A1 Novel Tricyclic Compounds ABBOTT LABORATORIES (US) 2011-08-04 — — US disclosed
WO-2011068899-A1 NOVEL TRICYCLIC COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140349970-A1 NOVEL TRICYCLIC COMPOUNDS CCNI, IL2, IL4I1 AXL 4089/4885PRKCI 949/4885PLK1 2766/4885
US-20110190489-A1 Novel Tricyclic Compounds CCNI, IL2, IL4I1 AXL 4089/4885PRKCI 949/4885PLK1 2766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.